• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream

    7/16/25 7:00:00 AM ET
    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Major Chemicals
    Industrials
    Get the next $ADVM alert in real time by email

    MIAMI, July 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Conference on July 16 & 17, 2025.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    Questions@EmergingGrowth.com

    For updates, follow us on Twitter

    Day 1 – Presenting Today, July 16, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    BitFuFu Inc. (NASDAQ:FUFU)

    Keynote speaker: Charley Brady, VP Investor Relations

    9:40 – 10:10

    Impact Minerals Limited (ASX: IPT)

    Keynote speaker: Dr. Mike Jones, Managing Director

    11:25 – 11:55

    Faraday Future Intelligent Electric, Inc. (NASDAQ:FFAI)

    Keynote speakers: Jerry Wang, Global President

    12:35 – 1:05

    Adverum Biotechnologies (NASDAQ:ADVM)

    Keynote speaker: Jason Awe, PhD, MBA, Corporate Communications & IR

    1:10 – 1:40

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speakers: David Dodd, Chairman, President / CEO

    3:10 - 3:20

    Banzai International, Inc. (NASDAQ:BNZI)

    Keynote speaker: Joseph Davy, Co-Founder, Chairman & CEO

    3:25 - 3:35

    Interstellar Communication Holdings 

    Keynote speakers: Seda Hewitt, Space Ambassador of IcMercury Harri Laitinen, Lifeguard  of IcMercury, and Lijie Zhu, Captain of icMercury

    3:40 – 3:50

    Vizsla Royalties Corp. (TSXV:VROY) (OTCQB:VROYF)

    Keynote speaker: Michael N. Pettingell, President and CEO

    4:10 – 4:20

    Cyios Corp. (OTC:CYIO)

    Keynote speaker: John O'Shea, Chairman

    _______________________________________________________________

    Day 2 – Presenting Tomorrow July, 17, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Argenica Therapeutics Limited (ASX:AGN)

    Keynote speaker: Dr. Liz Dallimore, CEO & Managing Director

    9:40 – 10:10

    Uxin Limited (NASDAQ:UXIN)

    Keynote speaker: Feng Lin, CFO

    10:15 – 10:45

    ASP Isotopes Inc. (NASDAQ:ASPI)

    Keynote speaker: Paul Elliot Mann, CEO

    11:25 – 11:55

    Surf Air Mobility, Inc. (NYSE:SRFM)

    Keynote speakers: Deanna White, CEO and Oliver Reeves, CFO

    12:00 – 12:30

    Eshallgo, Inc. (NASDAQ:EHGO)

    Keynote speakers: Johnny Wu, President

    2:55 – 3:05

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    3:10 - 3:20

    Clene Inc., (NASDAQ:CLNN)

    Keynote speakers: Rob Etherington, President / CEO

    3:25 – 3:35

    Sono Group N.V. (OTCQB:SEVCF)

    Keynote speaker: George O'Leary, Managing Director, CEO and CFO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    Questions@EmergingGrowth.com

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: Conference@EmergingGrowth.com



    Primary Logo

    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $ASPI
    $BNZI
    $CLNN

    CompanyDatePrice TargetRatingAnalyst
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    ASP Isotopes Inc.
    $ASPI
    12/4/2025$13.00Overweight
    Cantor Fitzgerald
    Adverum Biotechnologies Inc.
    $ADVM
    11/17/2025Buy → Neutral
    H.C. Wainwright
    BitFuFu Inc.
    $FUFU
    8/13/2025$6.00Buy
    Roth Capital
    BitFuFu Inc.
    $FUFU
    7/18/2025Buy
    B. Riley Securities
    BitFuFu Inc.
    $FUFU
    6/18/2025$5.50Market Perform
    Northland Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$15.00 → $8.50Buy
    Alliance Global Partners
    More analyst ratings

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cantor Fitzgerald initiated coverage on ASP Isotopes with a new price target

    Cantor Fitzgerald initiated coverage of ASP Isotopes with a rating of Overweight and set a new price target of $13.00

    12/4/25 8:40:44 AM ET
    $ASPI
    Major Chemicals
    Industrials

    Adverum Biotech downgraded by H.C. Wainwright

    H.C. Wainwright downgraded Adverum Biotech from Buy to Neutral

    11/17/25 9:39:07 AM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    SEC Filings

    View All

    SEC Form EFFECT filed by Eshallgo Inc.

    EFFECT - EShallGo Inc. (0001879754) (Filer)

    4/3/26 12:15:18 AM ET
    $EHGO
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form PRE 14A filed by Banzai International Inc.

    PRE 14A - Banzai International, Inc. (0001826011) (Filer)

    4/2/26 5:28:13 PM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    SEC Form NT 10-K filed by Jaguar Health Inc.

    NT 10-K - Jaguar Health, Inc. (0001585608) (Filer)

    4/1/26 4:19:05 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Uxin to Report Fourth Quarter and Full Year 2025 Financial Results on April 10, 2026

    BEIJING, April 6, 2026 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (NASDAQ:UXIN), China's leading used car retailer, today announced that it will release its financial results for the fourth quarter and full year 2025 ended December 31, 2025, before the U.S. market opens on April 10, 2026. Uxin's management team will host a conference call on Friday, April 10, 2026, at 8:00 A.M. U.S. Eastern Time (8:00 P.M. Beijing/Hong Kong time on the same day) to discuss the financial results. In advance of the conference call, all participants must use the following link to complete the online registration process. Upon registering, each participant will receive access details for this confere

    4/6/26 5:00:00 AM ET
    $UXIN
    Real Estate

    Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF to Establish the First Scaled EAI Education System in the United States With Deployment of Its EAI Robotics Products and Technology

    2025 annual financial report showed that the Company's stockholders' equity turned from negative to positive. The EAI robotics business achieved a positive gross margin on products in its very first quarter of delivery this year and has set a target of over 1,000 units shipment by the end of 2026. Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future", "FF" or the "Company"), a California-based global Embodied AI (EAI) ecosystem company, today shared a weekly business update from YT Jia, Founder and Global Co-CEO of FF. This week's update will be in the form of a Q&A session with YT. This press release features multimedia. View the full release here: https://www.bu

    4/5/26 6:58:00 PM ET
    $FFAI
    Auto Manufacturing
    Industrials

    Faraday Future Announces Its Latest Robot, the FX Aegis Quadruped, has Completed Its Full Compliance Certification in the United States

    All FX Aegis robots delivered to date can now be converted to formal deliveries. The starting price of the FX Aegis series is $2,490, with an ecosystem skill package price of $1,000 for the second development version. FX Aegis is a professional, embodied AI quadruped robot designed for security and companionship. FF EAI robotics exceeds target of shipping 20 units in its first delivery month and achieves positive product gross margins in Q1 2026, targeting cumulative shipments of more than 1,000 units by the end of December 2026. Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future," "FF," or the "Company"), a California-based global Embodied AI (EAI) ecosystem

    4/2/26 7:12:00 PM ET
    $FFAI
    Auto Manufacturing
    Industrials

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Matlin David J bought $216,664 worth of shares (33,333 units at $6.50), increasing direct ownership by 7% to 477,824 units (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/13/26 2:48:54 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Co-Global CEO Aydt Matthias disposed of $100 worth of Series A Preferred Stock (1 units at $100.00) and bought $100 worth of Series A Preferred Stock (1 units at $100.00) (SEC Form 4)

    4 - FARADAY FUTURE INTELLIGENT ELECTRIC INC. (0001805521) (Issuer)

    12/29/25 4:15:07 PM ET
    $FFAI
    Auto Manufacturing
    Industrials

    CEO, PRESIDENT AND DIRECTOR Fischer Laurent bought $553,917 worth of shares (128,699 units at $4.30), increasing direct ownership by 177% to 201,513 units (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/8/25 9:45:06 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ugwumba Chidozie

    4 - Clene Inc. (0001822791) (Issuer)

    4/6/26 5:32:25 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Ugwumba Chidozie

    4 - Clene Inc. (0001822791) (Issuer)

    4/1/26 5:10:37 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Cui Joshua Kewei

    3 - Bitfufu Inc. (0001921158) (Issuer)

    4/1/26 10:18:05 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Leadership Updates

    Live Leadership Updates

    View All

    Quantum Leap Energy Appoints Nate Salpeter, Ph.D., a Key Opinion Leader in Fluid Dynamics and Energy Technology, as its Chief Technology Officer

    DALLAS, March 05, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASPI") today announced that Quantum Leap Energy LLC ("QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has appointed Nate Salpeter, Ph.D. as its Chief Technology Officer. Dr. Salpeter is a recognized key opinion leader in the field of physics-constrained energy technology optimization, with more than 15 years of experience building computational frameworks, laser-based experimental methods, and first-of-kind engineering programs across nuclear energy and advanced thermal sys

    3/5/26 7:30:00 AM ET
    $ASPI
    Major Chemicals
    Industrials

    Faraday Future Announces Its Launch of Multiple Robot Products in Three Categories at Its "Robot & Vehicle +" EAI Robotics Final Launch & FX Partner Recruitment Event February 4, 2026, in Las Vegas, NV, at the Annual NADA Show

    The event will be livestreamed at 3:30 p.m. PST on February 4 at https://www.ff.com/us/NADA2026/The first FF EAI Robotics product has completed U.S. regulatory certification and will begin sales in parallel with the launch event. LOS ANGELES, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future", "FF" or "Company"), a California-based global shared intelligent electric mobility ecosystem company, today announced additional details for its FF EAI Robotics Product Final Launch being held on February 4, 2026, at the annual National Automobile Dealers Association (NADA) Show in Las Vegas, NV. FF is inviting NADA attendees to join FF at th

    1/27/26 11:20:47 PM ET
    $FFAI
    Auto Manufacturing
    Industrials

    Faraday Future Announces its EAI Robotics Product Final Launch & FX Partner Recruitment Event Invitation Save the Date for February 4, 2026, in Las Vegas, NV, to Coincide with the Annual NADA Show

    LOS ANGELES, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Faraday Future", "FF" or "Company"), a California-based global shared intelligent electric mobility ecosystem company, today announced that it will be holding its FF EAI Robotics Product Final Launch on February 4, 2026, coinciding with the annual National Automobile Dealers Association (NADA) Show in Las Vegas, NV. Faraday Future is inviting NADA attendees to join us at the NADA Show for a landmark moment in the Company's evolution—the FF EAI Robotics Product Final Launch & FX Partner Recruitment Event. This event will bring together industry partners, investors, dealers, and media t

    1/15/26 2:26:33 AM ET
    $FFAI
    Auto Manufacturing
    Industrials

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Financials

    Live finance-specific insights

    View All

    Uxin to Report Fourth Quarter and Full Year 2025 Financial Results on April 10, 2026

    BEIJING, April 6, 2026 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (NASDAQ:UXIN), China's leading used car retailer, today announced that it will release its financial results for the fourth quarter and full year 2025 ended December 31, 2025, before the U.S. market opens on April 10, 2026. Uxin's management team will host a conference call on Friday, April 10, 2026, at 8:00 A.M. U.S. Eastern Time (8:00 P.M. Beijing/Hong Kong time on the same day) to discuss the financial results. In advance of the conference call, all participants must use the following link to complete the online registration process. Upon registering, each participant will receive access details for this confere

    4/6/26 5:00:00 AM ET
    $UXIN
    Real Estate

    FF Announces Fourth Quarter and Full Year 2025 Financial Results: Stockholders' Equity Turns Positive; First Month of EAI Robotics Delivery Beats Target with Positive Product Gross Margin

    Balance sheet strengthens with return to positive stockholders' equity following ~$100 million debt optimization. EAI robotics exceeds target of shipping 20 units in its first delivery month and achieves positive product gross margins in Q1 2026, establishing a scalable growth and cash flow engine, targeting cumulative shipments of more than 1,000 units by the end of December 2026. The Company expects to generate software-related revenue beyond device sales within 2026. EAI EV Strategy advances into validation and pre-production with a disciplined, cash-aligned ramp. FF is the first U.S. company to deliver both humanoid and bionic robots that utilize a self-reinforcing "Device-Dat

    3/31/26 5:23:00 PM ET
    $AIXC
    $FFAI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Auto Manufacturing
    Industrials

    Banzai Reports Fourth Quarter and Full Year 2025 Financial Results

    Full Year 2025 Revenue of $12.2 Million, up 169% from 2024  Revenue of $2.8 Million for Q4 2025, up 116% from Q4 2024 Gross Profit of $2.3 Million for Q4 2025, a 148% increase from Q4 2024; Gross Margin Expanded to 81.9% in Q4 2025, a 1,061 BPS Increase Reaches Deal to Acquire Assets of ConnectAndSell, a Profitable Company, More Than Doubling Annual Revenue and Expanding AI Platform Capabilities Management to Host Fourth Quarter and Full Year 2025 Results Conference Call Today, Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time SEATTLE, March 31, 2026 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ:BNZI) ("Banzai" or the "Company"), a leading AI-powered sales & marketing techno

    3/31/26 4:10:00 PM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $ASPI
    $BNZI
    $CLNN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:57:12 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:40:56 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by GeoVax Labs Inc.

    SC 13G/A - GeoVax Labs, Inc. (0000832489) (Subject)

    11/14/24 5:10:48 PM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care